Some Current Concepts of the Pneumoconioses

Total Page:16

File Type:pdf, Size:1020Kb

Some Current Concepts of the Pneumoconioses A n n a l s o f C l i n i c a l L a b o r a t o r y S c i e n c e , Vol. 3, No. 3 Copyright © 1973, I n s t i t u t e for Clinical Science Some Current Concepts of the Pneumoconioses GONZALO E. APONTE, M.D. Jefferson Medical College, Department of Pathology, Philadelphia, PA 19107 ABSTRACT Selected aspects of the pneumoconioses are briefly reviewed. Coal-workers pneumoconiosis is a complex disease involving multiple pathogenetic factors which can modify the outcome considerably. The development of diffuse pul­ monary fibrosis in some patients may be determined by immunologic mecha­ nisms. The risk of neoplasia from occupational exposure to asbestos is great, and the tumors develop irrespective of the extent of pulmonary fibrosis. Chrysotile fibers can be identified frequently in the lungs of urban dwellers without occupational exposure. Chronic berylliosis is truly a systemic disease, and its manifestations include hyperglobulinemia, decreased tuberculin re­ activity, hyperuricemia and hypercalciuria. The extrinsic allergic pneumonias, secondary to the inhalation of various dusts of vegetable origin, are thought to develop from the deposition of immune complexes within pulmonary blood vessels. Coal-Worker’s Pneumoconiosis (CWP) paired by disorders such as chronic bron­ The pathogenesis of coal-workers pneu­ chitis and fibrocystic disease of the pan­ moconiosis is complex and not fully under­ creas; the latter by alveolar proteinosis and stood. It appears that the coal in the dust idiopathic pulmonary microlithiasis. In can serve as the primary etiologic agent, 1969, Buechner and Ansari2 described a but other factors which often play import­ new variant of acute silicosis in sandblasters ant modifying roles include (1) the silica which they termed silicoproteinosis. There content of the dust, (2) air pollution by were four patients who developed, within agents such as hydrocarbons and nitrogen an average of 4 years after exposure, a oxides, (3) cigarette smoking, (4) co­ rapidly fatal disease characteristic of acute existent tuberculosis and (5) constitutional silicosis clinically but with histopathologic factors, such as an associated impairment changes of alveolar proteinosis. in the mechanism whereby the respiratory The characteristic lesion in the simple tract clears itself of foreign particles. This (uncomplicated) type of coalworker’s pneu­ mechanism has two components— (1) mu­ moconiosis is a multifocal, avascular nodu­ cociliary “escalator” action of tracheobron­ lar fibrosis. The reacting cells most prob­ chial epithelial cells and (2) alveolar clear­ ably originate from the alveolar membrane ance. The former may be significantly im­ and not from the blood.3 Coal dust itself 2 2 0 APONTE stimulates the production of some reticulin dose-tumor response curve are crucial ques­ fibers, but the amount of collagen produced tions which remain unanswered. depends largely on the silica content. Pro­ An even more important problem is the gressive massive pulmonary fibrosis devel­ extent of non-occupational exposure through ops in a minority of cases and acid-fast environmental pollution or other sources. bacilli have been demonstrated in about 40 That this can be significant was suggested percent of such patients. Experimentally, by epidemiologic studies reported from simple CWP can be converted into the South Africa in I96020 and from London in massive progressive type by the synergistic 1965,9 in which a significant number of effects of virulent or avirulent tubercle cases of mesothelioma were found to occur bacilli or nonfibrogenic dusts. It is likely, in persons with only “family” or “neighbor­ but not yet proved, that the “conversion hood” exposure. The subsequent frequent factors” are immunologic.3 demonstration of asbestos bodies in the It is well known that patients with rheu­ lungs of urban dwellers did not settle the matoid arthritis and co-existent lung dis­ question since it was not proved that their ease are prone to develop multiple periph­ cores were invariably asbestos. The search, eral pulmonary nodules which resemble with the light microscope, for asbestos fibers histologically the subcutaneous rheumatoid and fibrils in digested sections of lungs has nodules, as well as a diffuse type of pul­ yielded positive results in nearly 50 percent monary fibrosis.14 The association with of the cases. The technique, however, is pneumoconiosis, described as Caplan’s syn­ hampered by a high incidence of back­ drome, has been noted in coal workers, ground contamination and by the fact that foundry workers and boiler scalers, as well the fibrils less than 1 ¡x in diameter, which as in a few cases of asbestosis. More re­ are more characteristic of chrysotile asbes­ cently, the analogue of Caplans syndrome tos (the type most prevalent in the USA), has been reported in a sandblaster with are less numerous and more difficult to scleroderma.22 identify. Specific identification requires techniques such as electron microscopy and A sbestosis electron microprobe analysis. Two studies The risk of malignant neoplasm from oc­ which utilized the former method have cupational exposure to asbestos is consider­ been reported recently by Selikoff and asso- able. Among asbestos insulation workers in ciates16 from New York and by Pooley and New York City,15 about one in five deaths others12 from London. In both, a high inci­ is due to lung cancer and one in 10 to dence of asbestos fibers was found in the mesotheliomas, gastrointestinal neoplasms lungs of urban dwellers. The former group or cor pulmonale. There is a predominance of investigators also has found chrysotile of lower-lobe origin in asbestos-associated asbestos in about 33 percent of samples of lung cancers. Some, but not others,4 have 17 widely used drugs, including antibiotic also found a higher incidence of peripheral agents.11 Precisely what all this means in tumors and of adenocarcinomas. These neo­ terms of disease for persons who are ex­ plasms occur with increased frequency even posed non-occupationally perhaps will be in workers with little or no radiologic evi­ determined by future quantitative studies. dence of pulmonary fibrosis; and the few reported data indicate that the asbestos Berylliosis content of the lungs is quite small (0.6 per­ The use of beryllium in the United States cent or less).16 Whether or not there exists has increased 500-fold during the past 20 a threshold dose and the nature of the years. Chronic berylliosis, which also can CURRENT CONCEPTS OF THE PNEUMOCONIOSES 221 occur from non-occupational neighborhood ease, develops in persons who work with exposure, develops in only a small percent aluminum abrasives. The fumes contain of those exposed, but the factors which de­ about 7 percent silica, but typical silicotic termine individual susceptibility are un­ nodules have not been found in the re­ known. It is truly a systemic disease inas­ ported cases and the etiology of the pul­ much as high concentrations of beryllium monary changes remains obscure. have been found in almost every organ, ex­ Most cases of pulmonary disease follow­ cept perhaps the brain, whether or not the ing exposure to aluminum have appeared > tissue shows histopathologic changes. The in the European medical literature. The metal can also be detected in tissue sections particles of aluminum metal powder usually by laser microprobe and emission spec- are larger than 5 /i, but smaller ones ap­ V troscopy.13 Pulmonary fibrosis characteristi- parently are present in sufficient concen­ „ cally is most marked in the upper lobes, tration to become a hazard in selected in­ although the average beryllium content is stances. The pulmonary lesion is an inter­ > not greater in the upper lobes than in the stitial fibrosis similar to that seen in bauxite others. lung, the most severe changes being located Four additional findings which deserve near the pulmonary hila. * mention because they are relatively fre- Silica does not play a role in the patho­ > quent include (1) decreased tuberculin re­ genesis of the massive pulmonary fibrosis activity (without increase in the incidence which may develop in some carbon-elec- * of tuberculosis),19 (2) hyperglobulinemia trode makers. The lesions are thought to in about 40 percent, (3) hyperuricemia,5 result from the additive effects of carbon apparently due to decreased renal clearance dust and low-grade tuberculosis infection. * rather than increased production, and (4) The inhalation of dust from fiberglass *, hypercalciuria (20 percent),19 associated in fewer instances with hypercalcemia or renal plastic reportedly has produced pulmonary " stones, or both. reactions in human beings, and the irritant is calcium carbonate. Other Mineral Dusts Silver-polishers lung was first described Many other types of pneumoconiosis sec- in 1945. The dust inhaled contains iron ’ ondary to mineral dusts have been recog- oxide and metallic silver. The latter com­ ^ nized,1’18 but there is no space here to re­ bines with tissue proteins and stains the view them adequately. Silica or silicates tissues black. * are the principal cause of the pulmonary Stannosis results from prolonged inhala­ fibrosis after occupational exposure to tion of dust or fumes of tin oxide. The graphite, fuller earth, talc and Kaolin particles are deposited in the alveolar septa, ' (china clay), as well as in arc-welder’s subpleurally and around bronchioles and *. lung. blood vessels, but do not elicit much fibrosis. The pulmonary lesions from hematite are Acute exposures to fumes containing cad­ 1 due to silica modified by the presence of m ium can produce fatal pulmonary edema j iron. It resembles the pneumoconiosis of and chemical pneumonia. The changes in coal workers and involves the upper lobes ' 1 most severely. The serum concentration of cases of chronic exposure consist of moder­ » inorganic iron is elevated in some patients. ately severe perivascular fibrosis and infil­ The complications include bronchiectasis, tration with lymphocytes. Proteinuria is a ‘ tuberculosis, and pulmonary carcinoma, common finding and the urine contains t Bauxite lung, also known as Shaver’s dis­ complexes of cadmium and protein.
Recommended publications
  • Interstitial Lung Diseases in Developing Countries
    Rivera-Ortega P and Molina-Molina M. Interstitial Lung Diseases in Developing Countries. Annals of Global Health. 2019; 85(1): 4, 1–14. DOI: https://doi.org/10.5334/aogh.2414 REVIEW Interstitial Lung Diseases in Developing Countries Pilar Rivera-Ortega*,† and Maria Molina-Molina*,† More than 100 different conditions are grouped under the term interstitial lung disease (ILD). A diag- nosis of an ILD primarily relies on a combination of clinical, radiological, and pathological criteria, which should be evaluated by a multidisciplinary team of specialists. Multiple factors, such as environmental and occupational exposures, infections, drugs, radiation, and genetic predisposition have been implicated in the pathogenesis of these conditions. Asbestosis and other pneumoconiosis, hypersensitivity pneumonitis (HP), chronic beryllium disease, and smoking-related ILD are specifically linked to inhalational exposure of environmental agents. The recent Global Burden of Disease Study reported that ILD rank 40th in relation to global years of life lost in 2013, which represents an increase of 86% compared to 1990. Idiopathic pulmonary fibrosis (IPF) is the prototype of fibrotic ILD. A recent study from the United States reported that the incidence and prevalence of IPF are 14.6 per 100,000 person-years and 58.7 per 100,000 persons, respectively. These data suggests that, in large populated areas such as Brazil, Russia, India, and China (the BRIC region), there may be approximately 2 million people living with IPF. However, studies from South America found much lower rates (0.4–1.2 cases per 100,000 per year). Limited access to high- resolution computed tomography and spirometry or to multidisciplinary teams for accurate diagnosis and optimal treatment are common challenges to the management of ILD in developing countries.
    [Show full text]
  • Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy
    395 Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy Ferran Morell, MD1,2 Ana Villar, MD2,3 Iñigo Ojanguren, MD2,3 Xavier Muñoz, MD2,3 María-Jesús Cruz, PhD2,3 1 Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Catalonia, Spain Address for correspondence Ferran Morell, MD, Vall d’Hebron Institut 2 Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain de Recerca (VHIR), PasseigValld’Hebron, 119-129, 08035 Barcelona, 3 Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Catalonia, Spain (e-mail: [email protected]). Barcelona, Spain Semin Respir Crit Care Med 2016;37:395–405. Abstract This review presents an update of the currently available information related to Keywords hypersensitivity pneumonitis, with a particular focus on the contribution of several ► hypersensitivity techniques in the diagnosis of this condition. The methods discussed include proper pneumonitis elaboration of a complete medical history, targeted auscultation, detection of specific ► bronchoalveolar immunoglobulin G antibodies against the most common antigens causing this disease, lavage skin tests, antigen-specific lymphocyte activation assays, bronchoalveolar lavage, and ► fi speci c inhalation cryobiopsy. Special emphasis is placed on the relevant contribution of specificinhalation challenge challenge (bronchial challenge test). Surgical lung biopsy is presented as the ultimate ► bronchial challenge recourse, to be used when the diagnosis cannot be reached through the other methods test covered.
    [Show full text]
  • Workers' Compensation for Occupational Respiratory Diseases
    ORIGINAL ARTICLE http://dx.doi.org/10.3346/jkms.2014.29.S.S47 • J Korean Med Sci 2014; 29: S47-51 Workers’ Compensation for Occupational Respiratory Diseases So-young Park,1 Hyoung-Ryoul Kim,2 The respiratory system is one of the most important body systems particularly from the and Jaechul Song3 viewpoint of occupational medicine because it is the major route of occupational exposure. In 2013, there were significant changes in the specific criteria for the recognition of 1Occupational Lung Diseases Institute, Korea Workers’ Compensation & Welfare Service, Ansan; occupational diseases, which were established by the Enforcement Decree of the Industrial 2Department of Occupational and Environmental Accident Compensation Insurance Act (IACIA). In this article, the authors deal with the Medicine, College of Medicine, the Catholic former criteria, implications of the revision, and changes in the specific criteria in Korea by University of Korea, Seoul; 3Department of focusing on the 2013 amendment to the IACIA. Before the 2013 amendment to the IACIA, Occupational and Environmental Medicine, Hanyang University College of Medicine, Seoul, occupational respiratory disease was not a category because the previous criteria were Korea based on specific hazardous agents and their health effects. Workers as well as clinicians were not familiar with the agent-based criteria. To improve these criteria, a system-based Received: 20 December 2013 structure was added. Through these changes, in the current criteria, 33 types of agents Accepted: 6 April 2014 and 11 types of respiratory diseases are listed under diseases of the respiratory system. In Address for Correspondence: the current criteria, there are no concrete guidelines for evaluating work-relatedness, such Hyoung-Ryoul Kim, MD as estimating the exposure level, latent period, and detailed examination methods.
    [Show full text]
  • Silicosis: Pathogenesis and Changklan Muang Chiang Mai 50100 Thailand; Tel: 66 53 276364; Fax: 66 53 273590; E-Mail
    Central Annals of Clinical Pathology Bringing Excellence in Open Access Review Article *Corresponding author Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Silicosis: Pathogenesis and Changklan Muang Chiang Mai 50100 Thailand; Tel: 66 53 276364; Fax: 66 53 273590; E-mail: Biomarkers Submitted: 04 October 2018 Accepted: 31 October 2018 1,2 3 Attapon Cheepsattayakorn * and Ruangrong Cheepsattayakorn Published: 31 October 2018 1 10 Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand ISSN: 2373-9282 2 Department of Disease Control, Ministry of Public Health, Thailand Copyright 3 Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand © 2018 Cheepsattayakorn et al. OPEN ACCESS Abstract Ramazzini first described this disease, namely “Pneumonoultramicroscopicsilicovolcanokoniosis” Keywords and then was changed according to the types of exposed dust. No reliable figures on the silica- • Silicosis inhalation exposed individuals are officially documented. How silica particles stimulate pulmonary • Biomarkers response and the exact path physiology of silicosis are still not known and urgently require further • Pathogenesis research. Nevertheless, many researchers hypothesized that pulmonary alveolar macrophages play a major role by secreting fibroblast-stimulating factor and re-ingesting these ingested silica particles by the pulmonary alveolar macrophage with progressive magnification. Finally, ending up of the death of the pulmonary alveolar macrophages and the development of pulmonary fibrosis appear. Various mediators, such as CTGF, FBRS, FGF2/bFGF, and TNFα play a major role in the development of silica-induced pulmonary fibrosis. A hypothesis of silicosis-associated abnormal immunoglobulins has been postulated. In conclusion, novel studies on pathogenesis and biomarkers of silicosis are urgently needed for precise prevention and control of this silently threaten disease of the world.
    [Show full text]
  • Etiology and Aggravation in Thoracic Medicine
    DePaul Law Review Volume 21 Issue 1 Fall 1971: Medico-Legal Symposium II Article 6 Etiology and Aggravation in Thoracic Medicine W. B. Buckingham Follow this and additional works at: https://via.library.depaul.edu/law-review Recommended Citation W. B. Buckingham, Etiology and Aggravation in Thoracic Medicine, 21 DePaul L. Rev. 103 (1971) Available at: https://via.library.depaul.edu/law-review/vol21/iss1/6 This Article is brought to you for free and open access by the College of Law at Via Sapientiae. It has been accepted for inclusion in DePaul Law Review by an authorized editor of Via Sapientiae. For more information, please contact [email protected]. ETIOLOGY AND AGGRAVATION IN THORACIC MEDICINE W. B. BUCKINGHAM* INTRODUCTION N THE practice of thoracic medicine, misconceptions about the etiology and/or the aggravation of thoracic diseases are common- place. These errors are frequently perpetuated by patients and occasionally by well-meaning lawyers and well-trained physicians. Superficial analysis indicates that most of these misconceptions arise from the concept of post hoc ergo propter hoc. In diseases affecting the thorax, multiple etiological factors commonly operate over pro- longed periods of time. Under such circumstances it is extremely difficult to sort out cause and effect. Thus, in light of the imperfec- tions in diagnosis, misconceptions about etiology and aggravation of disease can be appreciated. There are substantial limitations and uncertainties to any medical diagnosis. The semantic derivation of the word "diagnosis" comes through the Greek words whose meaning is "to know through" or "to understand by means of the manifestations of." A complete diagnosis in the modem sense of the term is a disease entity in which the causative mechanisms are clearly understood, and the man- ifestations readily appreciated both in clinical signs and symptoms and in laboratory findings.
    [Show full text]
  • Nebulizers: Diagnosis Codes – Medicare Advantage Policy Appendix
    UnitedHealthcare® Medicare Advantage Policy Appendix: Applicable Code List Nebulizers: Diagnosis Codes This list of codes applies to the Medicare Advantage Policy Guideline titled Approval Date: September 8, 2021 Nebulizers. Applicable Codes The following list(s) of procedure and/or diagnosis codes is provided for reference purposes only and may not be all inclusive. The listing of a code does not imply that the service described by the code is a covered or non-covered health service. Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may require coverage for a specific service. The inclusion of a code does not imply any right to reimbursement or guarantee claim payment. Other Policies and Guidelines may apply. Diagnosis Code Description For HCPCS Codes A7003, A7004, and E0570 A15.0 Tuberculosis of lung A22.1 Pulmonary anthrax A37.01 Whooping cough due to Bordetella pertussis with pneumonia A37.11 Whooping cough due to Bordetella parapertussis with pneumonia A37.81 Whooping cough due to other Bordetella species with pneumonia A37.91 Whooping cough, unspecified species with pneumonia A48.1 Legionnaires' disease B20 Human immunodeficiency virus [HIV] disease B25.0 Cytomegaloviral pneumonitis B44.0 Invasive pulmonary aspergillosis B59 Pneumocystosis B77.81 Ascariasis pneumonia E84.0 Cystic fibrosis with pulmonary manifestations J09.X1 Influenza due to identified novel influenza A virus with pneumonia J09.X2 Influenza due to identified novel influenza A virus with other
    [Show full text]
  • Differential Diagnosis of Granulomatous Lung Disease: Clues and Pitfalls
    SERIES PATHOLOGY FOR THE CLINICIAN Differential diagnosis of granulomatous lung disease: clues and pitfalls Shinichiro Ohshimo1, Josune Guzman2, Ulrich Costabel3 and Francesco Bonella3 Number 4 in the Series “Pathology for the clinician” Edited by Peter Dorfmüller and Alberto Cavazza Affiliations: 1Dept of Emergency and Critical Care Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan. 2General and Experimental Pathology, Ruhr-University Bochum, Bochum, Germany. 3Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany. Correspondence: Francesco Bonella, Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University of Duisburg-Essen, Tueschener Weg 40, 45239 Essen, Germany. E-mail: [email protected] @ERSpublications A multidisciplinary approach is crucial for the accurate differential diagnosis of granulomatous lung diseases http://ow.ly/FxsP30cebtf Cite this article as: Ohshimo S, Guzman J, Costabel U, et al. Differential diagnosis of granulomatous lung disease: clues and pitfalls. Eur Respir Rev 2017; 26: 170012 [https://doi.org/10.1183/16000617.0012-2017]. ABSTRACT Granulomatous lung diseases are a heterogeneous group of disorders that have a wide spectrum of pathologies with variable clinical manifestations and outcomes. Precise clinical evaluation, laboratory testing, pulmonary function testing, radiological imaging including high-resolution computed tomography and often histopathological assessment contribute to make
    [Show full text]
  • BERYLLIUM DISEASE by I
    Postgrad Med J: first published as 10.1136/pgmj.34.391.262 on 1 May 1958. Downloaded from 262 BERYLLIUM DISEASE By I. B. SNEDDON, M.B., Ch.B., F.R.C.P. Consultant Dermatologist, Rupert Hallam Department of Dermatology, Sheffield It is opportune in a symposium on sarcoidosis monary berylliosis which fulfilled the most to discuss beryllium disease because it mimics so stringent diagnostic criteria. closely the naturally occurring Boecks sarcoid and A beryllium case registry set up at the Massa- yet carries a far graver prognosis. chusetts General Hospital by Dr. Harriet Hardy Beryllium was first reported to possess toxic had collected by 1956 309 examples of the disease, properties by Weber and Englehardt (I933) in of whom 84 had died. The constant finding of Germany. They described bronchitis and acute beryllium in autopsy material from the fatal cases respiratory disease in workers extracting beryllium had proved beyond doubt the association between from ore. Similar observations were made by the granulomatous reaction and the metal. Marradi Fabroni (I935) in Italy and Gelman It is difficult to reconcile the paucity of accounts (I936) in Russia. Further reports came from of beryllium disease in this country with the large Germany in I942 where beryllium poisoning was amount of beryllium compounds which have been recognized as a compensatable disease. Towards used in the last ten The in the end of World War II the production and use years. only reports the medical literature are those of Agate (I948),copyright. of beryllium salts increased greatly in the United Sneddon (i955), and Rogers (1957), but several States, and in 1943 Van Ordstrand et al.
    [Show full text]
  • European Respiratory Society Classification of the Idiopathic
    This copy is for personal use only. To order printed copies, contact [email protected] 1849 CHEST IMAGING American Thoracic Society– European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 20021 Nicola Sverzellati, MD, PhD David A. Lynch, MB In the updated American Thoracic Society–European Respira- David M. Hansell, MD, FRCP, FRCR tory Society classification of the idiopathic interstitial pneumonias Takeshi Johkoh, MD, PhD (IIPs), the major entities have been preserved and grouped into Talmadge E. King, Jr, MD (a) “chronic fibrosing IIPs” (idiopathic pulmonary fibrosis and id- William D. Travis, MD iopathic nonspecific interstitial pneumonia), (b) “smoking-related IIPs” (respiratory bronchiolitis–associated interstitial lung disease Abbreviations: H-E = hematoxylin-eosin, and desquamative interstitial pneumonia), (c) “acute or subacute IIP = idiopathic interstitial pneumonia, IPF = IIPs” (cryptogenic organizing pneumonia and acute interstitial idiopathic pulmonary fibrosis, NSIP = nonspe- cific interstitial pneumonia, RB-ILD = respi- pneumonia), and (d) “rare IIPs” (lymphoid interstitial pneumonia ratory bronchiolitis–associated interstitial lung and idiopathic pleuroparenchymal fibroelastosis). Furthermore, it disease, UIP = usual interstitial pneumonia has been acknowledged that a final diagnosis is not always achiev- RadioGraphics 2015; 35:1849–1872 able, and the category “unclassifiable IIP” has been proposed. The Published online 10.1148/rg.2015140334 diagnostic interpretation of
    [Show full text]
  • Diapositivo 1
    A.C. Nunes1, A. Domingues1, M. Almeida-Silva1,2, S. Viegas2, C. Viegas2 1 Escola Superior de Tecnologia e Saúde de Lisboa, Instituto Politécnico de Lisboa 2 Instituto Tecnológico e Nuclear, Instituto Superior Técnico, Universidade Técnica de Lisboa. Cork is a light, porous, impermeable material extracted from the bark of some trees. The most widely used cork is obtained from the cork tree Health Effects (Quercus suber). It is estimated that the area occupied by cork oaks in the Iberian Peninsula is around 33% in Portugal and 23% in Spain [1]. The studied articles refer two major diseases associated with this Portugal is the largest cork producing country in the world, followed by occupational setting, occupational asthma and Suberosis. Spain, and its industry is an important economical resource [2].The Occupational asthma is a disease whose origin is related to the processes used in the manufacture of cork depend on the end product to be obtained, being the production of stoppers for wine bottles the exposure to a particular factor in a workplace. Recent studies have main application. Most of the cork is stored under dark humid and identified Chrysonilia sitophila as a cause for this occupational disease moldy conditions. During the manufacturing process, workers are in the cork and logging industry [4, 5]. This fungi is a common mould exposed to an environment that is heavily contaminated with cork dust found in cork samples analyzed [6]. [3]. Due to this repeated exposure to moldy cork dust, cork workers are at risk for developing occupational lung diseases such as occupational Suberosis is the term applied to hypersensitivity pneumonitis due to asthma and Suberosis.
    [Show full text]
  • Occupational Lung Disease - American Lung Association Site
    Lung Disease Data at a Glance: Occupational Lung Disease - American Lung Association site Sick Building Syndrome Racial Disparity Prevention: Monitor Safety and Recognize Breathing Hazards Changing the Face of Occupational Lung Disease Research ● Occupational lung disease is the number-one cause of work-related illness in the United States in terms of frequency, severity and preventability. ● Worldwide, about 20 percent to 30 percent of the male and five percent to 20 percent of the female working-age population may have been exposed to agents that cause cancer in the lungs during their working lives. ● Occupational asthma is the most prevalent occupational lung disease in the United States. Approximately 15 percent of asthma cases in the United States are due to occupational exposures. ● The cost of occupational injuries and illnesses in the United States totals more than $170 billion. In 2002, there were about 294,500 newly reported cases of occupational illness in private industry. ● A total of 2,591 work-related respiratory illnesses with days away from work (2.4 per 100,000 workers) occurred in private workplaces in 2000. The highest total for days away from work due to respiratory illnesses was in the manufacturing sector. ● In 2002, African Americans made up 18.8 percent of the 800,000 textile workers. Exposure to dusts generated while processing cotton can cause byssinosis, a chronic condition that results in blocked airways and impaired lung function. Between 1990 and 1999, African-American males had an age-adjusted mortality rate due to byssinosis that was 80 percent greater than White males. ● It is estimated that African Americans accounted for 20.7 percent of the 3.1 million cleaning and building service jobs, which involve exposure to noxious chemicals and biological contaminants.
    [Show full text]
  • Preventing Postoperative Pulmonary Complications the Role of the Anesthesiologist David O
    1467 Ⅵ CLINICAL CONCEPTS AND COMMENTARY Richard B. Weiskopf, M.D., Editor Anesthesiology 2000; 92:1467–72 © 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Preventing Postoperative Pulmonary Complications The Role of the Anesthesiologist David O. Warner, M.D.* THE Confederate General “Stonewall” Jackson was one widely. Nonetheless, it is still clear that PPCs occur of the earliest known victims of a respiratory complica- relatively frequently. In studies of noncardiac surgery, tion after surgery, dying of pneumonia 10 days after an the frequency of PPCs and cardiac complications (which otherwise successful ether anesthetic in 1863. Despite historically have attracted more attention from the anes- subsequent advances in anesthesia and surgical care, thesia community) are comparable.1 For example, in a postoperative pulmonary complications (PPCs) still are a series of adult men undergoing elective abdominal sur- significant problem in modern practice. This commen- gery, PPCs occurred significantly more frequently than tary examines why PPCs occur and how the anesthesi- cardiac complications (estimated rates of 9.6% and 5.7%, ologist can help prevent them. respectively) and were associated with significantly longer hospital stays.1 Significance of Perioperative Pulmonary Causes of Perioperative Pulmonary Complications Complications Determination of the frequency and clinical impact of A basic understanding of mechanism guides rational PPCs in modern practice is hampered by the lack of a practice. Many PPCs, such as atelectasis and pneumonia, uniform definition of a PPC among studies. Nearly all seem to be related to disruption of the normal activity of investigators include in this definition pneumonia (defi- the respiratory muscles, disruption that begins with the nite or suspected), respiratory failure (usually defined as induction of anesthesia and that may continue into the the need for mechanical ventilatory support), and bron- postoperative period.
    [Show full text]